use of a material that absorbs light, and method to improve the appearance of the skin or inhibit ha

专利摘要:
BISQUATERNARY ALKALOID SALT. The invention is directed to novel bisquaternary quinine alkaloid salts and the use of bisquaternary quinine alkaloid salts in asymmetric phase transfer catalysis.
公开号:BR112014026012B1
申请号:R112014026012-5
申请日:2013-03-14
公开日:2021-04-20
发明作者:Dilip Paithankar；Richard Dean Blomgren；Richard Rox Anderson；William A. Farinelli；Apostolos G. Doukas
申请人:The General Hospital Corporation；
IPC主号:

专利说明:

RELATED PATENT APPLICATION DATA
[0001] This patent application claims the benefit of US Provisional Patent Application Serial No. 61/636,381, filed April 20, 2012 and US Utility Patent Application Serial No. 13/789,575, filed 7 March 2013. All contents of the aforementioned patent applications are hereby incorporated by reference.
[0002] This patent application may contain subject matter that is related to that described and claimed in U.S. Patent Application No. 2012/0059307 A2, published March 8, 2012, the contents of which are incorporated herein by reference. FUNDAMENTALS OF THE INVENTION
[0003] Acne vulgaris is a follicular skin disorder that is characterized by the appearance of comedones, papules, nodules and cysts. Comedones are hair follicles that are blocked with a keratin plug. Open comedones, those in which the keratin plug is visible, form “black tips” and closed comedones form “white tips” that often progress to inflamed papules, nodules, and cysts. The presence of bacteria in a follicle attracts white blood cells to the follicle, which can cause an inflammatory response seen as papules (red spots on the skin), pustules and nodules. Acne can be secondary, where only a few comedones or papules are present, or it can be highly inflammatory and leave disfiguring scars. Improved methods of treating or alleviating follicular skin conditions, such as acne vulgaris, are required. SUMMARY OF THE INVENTION
[0004] As described below, the present invention provides methods for treating or alleviating follicular skin diseases (eg, acne) in an individual (eg, a human) and compositions comprising submicron particles that absorb energy (eg, light ) (e.g., nanoparticles comprising a silica core and a gold shell) and methods for dispensing such particles by topical administration, e.g., into a hair follicle, sebaceous duct, and/or sebaceous gland, for use accordingly with the methods.
[0005] Thus, in one aspect, the invention provides a method of treating or alleviating a follicular skin disease in an individual, the method comprising: topically applying a formulation comprising submicron particles comprising a material that absorbs light to the individual's skin; facilitate the dispensing of material into a hair follicle, sebaceous gland, sebaceous gland duct, or infundibular of the skin by mechanical agitation, acoustic vibration, ultrasound, alternating suction and pressure, or micro-jets; and exposing the submicron particles to energy activation, thereby treating or alleviating follicular skin disease in the individual.
[0006] In another aspect, the invention provides a method of improving the appearance of enlarged pores in the skin of an individual, the method comprising: topically applying a formulation comprising submicron particles comprising a material that absorbs light to the skin of the individual; facilitate the dispensing of materials to a hair follicle, sebaceous gland, sebaceous gland duct or infundibular skin by mechanical agitation, acoustic vibration, ultrasound, alternating suction and pressure or micro-jets; and exposing submicron particles to energy activation, thereby improving the appearance of enlarged pores in the individual's skin.
[0007] In yet another aspect, the invention provides a method of improving the appearance of oily skin of an individual, the method comprising: topically applying a formulation comprising submicron particles comprising a material that absorbs light to the skin of the individual; facilitate the dispensing of submicron particles to a hair follicle, sebaceous gland, sebaceous gland duct, or infundibular skin by mechanical agitation, acoustic vibration, ultrasound, alternating suction and pressure, or micro-jets; and expose the submicron particles to energy activation, thus improving the individual's oily skin appearance.
[0008] Another aspect of the invention provides a method for permanently removing hair from an individual, the method comprising: topically applying a light absorbing material to the individual's skin and exposing the material to energy activation, thereby permanently removing the hair. In one modality, hair is lightly pigmented or thin hair. In another embodiment, the method further comprises shaving the hair from the individual's follicle before topically applying the light-absorbing material to the individual's skin and exposing the material to energy activation.
[0009] In another aspect, the invention provides a method of thermally treating hyperhidrosis by damaging eccrine glands or their surrounding area, the method comprising: topically applying a light-absorbing material to an individual's skin and exposing the material to energy activation, permanently thus removing the glands and treating hyperhidrosis.
[00010] In yet another aspect, the invention provides a method of facilitating the dispensing of a material that absorbs light to a target volume on the skin of an individual to obtain a therapeutic effect, the method comprising: topically applying a formulation comprising a material which absorbs light on the individual's skin to deliver the material to a reservoir in the skin; facilitate the dispensing of the material to a target volume on the individual's skin by radiating into the skin with a first series of light pulses; and exposing the light-absorbing material to a second series of light pulses to heat the material and thermally damage the target volume to achieve a therapeutic effect.
[00011] In yet another aspect, the invention provides a method of facilitating the dispensing of a material that absorbs light to a target volume on the skin of an individual to obtain a therapeutic effect, the method comprising: topically applying a formulation comprising a material that absorbs light into the individual's skin; facilitate the dispensing of material to a reservoir on the skin by mechanical agitation; facilitate dispensing of material to a target volume on the skin by applying a train of low energy laser pulses each pulse taking one microsecond or less to trigger material in the target volume; and exposing the light-absorbing material to a second series of low-energy laser pulses to heat the material and thermally damage the target volume to achieve a therapeutic effect.
[00012] Yet another aspect of the invention provides a method of treating or alleviating a follicular skin disease of an individual, the method comprising: topically applying a formulation comprising a submicron particle comprising a material that absorbs light to the individual's skin; facilitate the dispensing of skin material into a hair follicle by acoustically created micro-jets in the formulation; and exposing the submicron particle to energy activation, thus treating follicular skin disease.
[00013] In yet another aspect, the invention provides a method of treating or alleviating a follicular skin disease of an individual, the method comprising: exposing the individual's skin to a formulation comprising submicron particles comprising a material that absorbs light; and facilitating dispensing of skin material into a hair follicle by low-frequency ultrasound-induced cavitation in the formulation close to the skin surface adjacent to the hair follicle; and expose the submicron particles to energy activation, thus treating follicular skin disease.
[00014] Yet another aspect of the invention provides a method of facilitating the dispensing of a light-absorbing material to a target volume on the skin of an individual, the method comprising: topically applying a formulation comprising a light-absorbing material on the individual's skin to deliver the material to a reservoir in the target skin volume; facilitate dispensing of material to a target volume on the individual's skin substantially via a transfollicular path; and exposing the light-absorbing material to a series of light pulses to heat the material and thermally damage the target volume to achieve a therapeutic effect.
[00015] In another aspect, the invention provides a method of treating or alleviating a follicular skin disease of an individual, the method comprising: topically applying a formulation comprising particles of a light absorbing material to the individual's skin; acoustically cavitate the formulation to selectively facilitate the dispensing of particles in the formulation into a sebaceous gland primarily via the corresponding hair follicle; and irradiating the particles with light to treat follicular skin disease.
[00016] Another aspect of the invention provides a method of treating or alleviating a follicular skin disease of an individual, the method comprising: topically applying a formulation comprising submicron particles comprising a material that absorbs light to the skin of the individual; dispensing the formulation into one or more sebaceous glands substantially via a transfollicular pathway; and expose the submicron particles to energy activation, thus treating follicular skin disease.
[00017] Yet another aspect of the invention provides a method of treating or alleviating a follicular skin disease of an individual, the method comprising: topically applying a formulation comprising a submicron particle comprising a material that absorbs light to the individual's skin; facilitate dispensing of material into a hair follicle by low-frequency ultrasound-induced cavitation near the skin surface adjacent to the hair follicle; and treating or alleviating follicular skin disease adjacent to the submicron particle using heat produced by irradiating the submicron particle with light.
[00018] The above described method aspects of the invention or the invention aspects described herein include a plurality of used embodiments that are universally applicable to the methods of the invention described herein.
[00019] Thus, in one modality, dispensing the material that absorbs light, for example, in the hair follicle, is facilitated by micro-jets created by ultrasound in the formulation.
[00020] In another embodiment, submicron particles for energy activation comprises irradiating the submicron particle with light, thus heating the particle.
[00021] In another embodiment, submicron particles are in a sebaceous gland during irradiation. In one embodiment, the submicron particles are substantially completely in the sebaceous gland during irradiation. In another embodiment, submicron particles are in a sebaceous gland duct during irradiation. In yet another embodiment, the submicron particles are substantially completely in the sebaceous gland duct during irradiation. In yet another embodiment, the submicron particles are in an infundibular involved in follicular skin disease.
[00022] In certain embodiments, the light-absorbing material in the formulation comprises a photoactive compound, photodynamic therapy (PDT) prodrug or PDT drug.
[00023] In one modality, the application of ultrasound is at a frequency in the range of 20 kHz to 500 kHz. In another modality, the application of ultrasound is at a frequency in the range of 20 kHz to 100 kHz. In yet another modality, the application of ultrasound is at a frequency in the range of 20 kHz to 60 kHz. In yet another modality, the application of ultrasound energy is at a frequency in the range of 30 kHz to 50 kHz.
[00024] In one modality, the density of the ultrasound force is about 0.5 - 50 W/cm2. In another modality, the peak-to-peak amplitude shift of the ultrasound audible alarm face is in the range of 0.5 to 30 microns.
[00025] In certain embodiments, light-absorbing particles or material are classified with respect to the entrance to and along a pore of the follicle. In one embodiment, particles are rated from about 1 micron to about 5 microns. In another embodiment, the particles are from about 50 nm to about 250 nm in diameter. In yet another modality, the particles are nanoshells.
[00026] In certain other embodiments, submicron particle sizes according to the invention are selected with respect to passage through the hair follicle and into a hair follicle sebaceous gland. In one embodiment, the hair follicle is a terminal follicle. In another modality, the hair follicle is a villous follicle. In yet another modality, the hair follicle is a sebaceous follicle.
[00027] In one embodiment, the submicron particle size is between about 0.01 microns to about 1.0 microns. In another embodiment, the submicron particle size is between about 0.05 to about 0.25 microns.
[00028] In one embodiment, the facilitating step further comprises selecting characteristics for the micro-jets created by ultrasound to create bubbles in the formulation about the same size as the pore of the hair follicle. In another embodiment, the facilitating step further comprises selecting the characteristics for low frequency ultrasound-induced cavitation to create bubbles in the formulation about the same size as the hair follicle.
[00029] In other embodiments, the ultrasonic-created micro-jets in the formulation are at about 50 microns to about 100 microns from the individual's skin surface.
[00030] In certain embodiments, dispensing of the light-absorbing material is facilitated by an immersion cavitation step. In one embodiment, the facilitate step produces cavitation at about 50 - 100 microns from the skin surface. In another embodiment, the stratum corneum portion of the individual's skin portion exposed to the dispensing step remains intact.
[00031] In certain other modalities, dispensing, for example, substantially via a transfollicular path, of light-absorbing material, for example, into one or more sebaceous glands or hair follicles, is facilitated by low-frequency ultrasound-induced cavitation close to the surface of the skin adjacent to the hair follicle. In one embodiment, the induced cavitation is between about 50 microns to about 100 microns from the skin surface. In another embodiment, low-frequency ultrasound characteristics are selected such that induced cavitation near the skin surface leaves the stratum corneum intact.
[00032] In one embodiment, the follicular disease for treatment is hyperhidrosis. In certain modalities, the facilitate step dispenses particles into an eccrine gland via the eccrine gland duct.
[00033] In other modalities, the follicular disease for treatment is acne vulgaris. In still other modalities, the follicular disease for treatment is sebaceous hyperplasia. In still other modalities, the follicular disease for treatment is hirsutism.
[00034] In one embodiment, submicron particles are coated with PEG. In another embodiment the particles have an absorption peak between 700 and 1100 nm wavelength of light. In another embodiment, the submicron particles have a ratio of shell diameter to core diameter of between about 1.05 to about 2.0.
[00035] In another embodiment, the submicron particle is a nanoparticle or nanoshell. In certain embodiments, the nanoparticle or nanoshell has a diameter of from about 50 to about 300 nm (for example, 50, 75, 100, 125, 150, 175, 200, 250, 300 nm). In one embodiment, the nanoparticle or nanoshell has a diameter of about 50 to about 250 nm. In another embodiment, the nanoparticle has a diameter of about 150 nm.
[00036] In another embodiment, the nanoparticle is coated with PEG.
[00037] In yet another modality, the nanoparticle is a nanoshell. In certain embodiments, the nanoparticle comprises a silica core and a gold shell.
[00038] In certain embodiments, submicron particles comprise from about 0.5% to about 2% of the formulation. In one embodiment, the formulation comprises about 0.5 to about 2% of a suspension comprising nanoparticles. In another embodiment, the formulation comprises about 0.1 to about 10% of a suspension comprising nanoparticles.
[00039] In one embodiment, the formulation contains a surface active agent and/or is hydrophilic. In another embodiment, the formulation contains a surface-active agent and/or is lipophilic. In yet another embodiment, the formulation contains a surface-active agent and/or is liposomal. In certain embodiments, the surfactant is less than 10% of the formulation.
[00040] In certain embodiments, the formulation comprises a component with the ability to solubilize lipids. In one embodiment, the component is ethanol.
[00041] In one embodiment, the formulation comprises one or more of ethanol, isopropyl alcohol, propylene glycol, a surface active agent, and/or isopropyl adipate. In another embodiment, the formulation comprises hydroxypropyl cellulose (HPC) and carboxymethyl cellulose (CMC). In yet another embodiment, the formulation comprises any one or more of water, ethanol, propylene glycol, polysorbate 80, isopropyl diadipate, phospholipid and thickening agents.
[00042] In certain embodiments, the formulation has an optical density between 5-500. In one embodiment, the formulation has an optical density of about 75. In another embodiment, the formulation has an optical density of about 125. In another embodiment, the formulation has an optical density of about 250.
[00043] In certain embodiments, energy activation, eg light activation, is performed with a pulsed laser light that dispenses light energy at a wavelength that is absorbed by the particle. In one embodiment, pulsed laser light delivers light energy at a wavelength that is preferentially absorbed by the particle. In another modality, energy activation is performed with a continuous laser that dispenses light energy at a wavelength that is absorbed by the particle.
[00044] In one embodiment, light energy has a wavelength range of about 700 to about 1100 nm. In another embodiment, the light energy has a fluence of less than about 100 J/cm2 . In yet another embodiment, the light energy has a pulse duration of about 0.5 ms - 1000 ms.
[00045] In certain modalities, the skin is prepared for the method by heating, by removing the follicular contents, and/or by depilation. In one embodiment, the follicular contents are removed by a method comprising bringing the pore of the follicle into contact with adhesive polymers.
[00046] In certain other embodiments, the topically applied submicron particles are cleared from the skin prior to activation by energy. In one embodiment, the topically applied submicron particles are cleaned from the skin with the aid of a fluid, prior to the application of optical radiation. In another embodiment, the fluid is water, ethanol or acetone. In another embodiment, the fluid can be composed of one or more of water, solvents, surface active agents, alcohols.
[00047] In certain other modalities, the skin is warmed before, during, or after topical administration to a temperature sufficient to aid follicular dispensing. In one modality, heating is performed using ultrasound. In another modality, heating is carried out using steam. In yet another modality, heating is performed using hot packs. In yet another modality, heating is performed using hot towels. Generally, heating is not sufficient to cause pain, tissue damage, burns, or other heat-related effects on the skin. In one modality, the temperature is around 35-44°C. In another modality, the temperature is about 40-44°C. In yet another modality, the temperature is around 42°C.
[00048] In certain embodiments, the step of exposing further comprises placing a volume of the formulation into a container, such that the formulation is in contact with the individual's skin. In one embodiment, the step of facilitating further comprises placing an ultrasound applicator in the container and submerged in the formulation.
[00049] In one embodiment, the target volume is the sebaceous gland, the target volume is in the follicle under the skin.
[00050] In another aspect, the invention provides a composition comprising a cosmetically acceptable carrier and a plurality of plasmonic nanoparticles in an amount effective to induce thermomodulation in a target tissue region with which the composition is topically placed in contact.
[00051] In one embodiment, plasmonic nanoparticles are activated by exposure to energy dispensed from a non-linear excitation surface plasmon resonance source in the target tissue region. In another embodiment, the plasmonic nanoparticle comprises a metal, metallic composite, metal oxide, metallic salt, electrical conductor, electrical superconductor, electrical semiconductor, dielectric, quantum dot, or composite of a combination thereof. In yet another embodiment, a substantial amount of the plasmonic particles present in the composition comprise geometrically tuned nanostructures.
[00052] In one embodiment, plasmonic particles comprise any currently known or created geometric shape that absorbs light and generates plasmon resonance at a desired wavelength, including nanoplates, solid nanoshells, hollow nanoshells, nanorods, nanorice, nanospheres, nanofibers, nanowires, nanopyramids, nanoprisms, nanostars or a combination of these. In another embodiment, the plasmonic particles comprise silver, gold, nickel, copper, titanium, silicon, galadium, palladium, platinum or chromium.
[00053] In one embodiment, the cosmetically acceptable carrier comprises an additive, a colorant, an emulsifier, a fragrance, a humectant, a polymerizable monomer, a stabilizer, a solvent or a surface-active agent. In a particular embodiment, the surface-active agent is selected from the group consisting of sodium laureth 2-sulfate, sodium dodecyl sulfate, ammonium lauryl sulfate, octech-1/deceth-1 sodium sulfate, lipids, proteins, peptides or derivatives thereof. In another specific embodiment, the surface-active agent is present in the composition in an amount between about 0.1 and about 10.0% weight-to-weight of carrier.
[00054] In one embodiment, the solvent is selected from the group consisting of water, propylene glycol, alcohol, hydrocarbon, chloroform, acid, base, acetone, diethyl ether, dimethyl sulfoxide, dimethylformamide, acetonitrile, tetrahydrofuran, dichloromethane and acetate. ethyl.
[00055] In another embodiment, the composition comprises plasmonic particles that have an optical density of at least about 1 O.D. at one or more peak resonance wavelengths.
[00056] In yet another embodiment, the plasmonic particles comprise a hydrophilic or aliphatic coating, wherein the coating does not substantially adsorb on the skin of a mammalian subject and wherein the coating comprises polyethylene glycol, silica, silica oxide, polyvinylpyrrolidone, polystyrene , a protein or a peptide.
[00057] In one embodiment, thermomodulation comprises damage, ablation, lysis, denaturation, deactivation, activation, inflammation induction, activation of heat shock proteins, disruption of cell signaling or disruption in the cell microenvironment in the target tissue region.
[00058] In another embodiment, the target tissue region comprises a sebaceous gland, a component of a sebaceous gland, a sebocyte, a component of a sebocyte, sebum or infundibular hair follicle. In a specific modality, the target tissue region comprises a swelling, a bulb, a stem cell, a stem cell niche, a dermal papilla, a cortex, a cuticle, a hair sheath, a medulla, a pylori muscle, a Huxley layer or a Henle layer.
[00059] In another aspect, the invention provides a method for performing targeted tissue ablation to treat a mammalian subject in need thereof, comprising the steps of i) topically administering to the subject's skin surface a composition of the invention as described above ; ii) providing penetration means to redistribute plasmonic particles from the surface of the skin to a component of dermal tissue; and iii) cause light to irradiate the skin surface.
[00060] In one embodiment, the light source comprises excitation of mercury, xenon, deuterium or a metal halide, phosphorescence, glow, luminescence, light-emitting diode or sunlight.
[00061] In another modality, the penetration means comprise high frequency ultrasound, low frequency ultrasound, massage, iontophoresis, high pressure air flow, high pressure liquid flow, vacuum, pretreatment with fractional photothermolysis or dermis coat of arms or a combination thereof.
[00062] In yet another embodiment, irradiation comprises light with a wavelength of light between about 200 nm and about 10,000 nm, a fluence of about 1 to about 100 joules/cm2, a pulse width of about 1 fentosecond to about 1 second and a repetition frequency of about 1 Hz to about 1 THz.
[00063] In another aspect, the invention provides a composition comprising a cosmetically acceptable carrier, an effective amount of sodium dodecyl sulfate and a plurality of plasmonic nanoparticles in an effective amount to induce thermal damage in a target tissue region with which the composition is topically placed in contact, wherein the nanoparticles have an optical density of at least about 1 OD. at a resonance wavelength of about 810 nanometers or 1064 nanometers, where the plasmonic particles comprise a silica coating of about 5 to about 35 nanometers, where the acceptable carrier comprises water and propylene glycol.
[00064] In yet another aspect, the invention provides a system for laser hair ablation or acne treatment comprising a composition of the invention as described above and a source of plasmonic energy suitable for application to human skin.
[00065] The invention provides compositions, methods and systems to treat follicular skin diseases. Compositions and articles defined by the invention have been isolated, or otherwise manufactured in conjunction with the examples provided below. Other features and advantages of the invention will be apparent from the detailed description and claims. BRIEF DESCRIPTION OF THE DRAWINGS
[00066] Figure 1 is a micrograph showing thermal damage to the follicular epithelium and part of the sebaceous gland after dispensing a nanopeel suspension by massage.
[00067] Figure 2 is a photograph showing the skin surface after application of the nanoshell formulation with ultrasound facilitated dispensing. Excess formulation was wiped off the skin before this photograph was taken.
[00068] Figure 3 is a micrograph showing a follicle filled with dark colored nanoshells after ultrasound facilitated dispensing. No nanoshells are seen in the epidermis or dermis.
[00069] Figure 4 is a micrograph showing a hair follicle and surrounding skin after ultrasound dispensing of the nanoshells and laser irradiation visualized by hematoxylin and eosin (H&E dye). Selective thermal damage around the follicle is shown by the added black outline.
[00070] Figure 5 is a photograph showing the surface of the skin. Accumulation of nanoshells in the follicles is seen.
[00071] Figure 6 is a micrograph showing a follicle with a significant accumulation of nanoshells.
[00072] Figure 7 is a micrograph showing localized thermal damage to a follicle enveloping the sebaceous gland visualized using H&E stain.
[00073] Figure 8 is a table showing the effectiveness of nanopeel dispensing followed by laser treatment in a human clinical trial of black acne. DETAILED DESCRIPTION OF THE INVENTION
[00074] The invention features compositions comprising light/energy absorbing materials and methods that are used for their topical delivery to a target (e.g., a follicle, follicular infundibular, sebaceous gland) for the treatment of a follicular disease. Definitions
[00075] Unless otherwise defined, all technical and scientific terms used herein have the meaning commonly understood by a person skilled in the art to which this invention belongs. The following references provide one of the skills with a general definition of many of the terms used in this invention: Singleton et al., Dictionary of Microbiology and Molecular Biology (2nd ed. 1994); The Cambridge Dictionary of Science and Technology (Walker ed., 1988); The Glossary of Genetics, 5th Ed., R. Rieger et al. (eds.), Springer Verlag (1991); and Hale & Marham, The Harper Collins Dictionary of Biology (1991). As used herein, the following terms have the meanings described below, unless otherwise specified.
[00076] Rqt "clivicr" gpVgpfg is to diminish, suppress, attenuate, diminish, arrest or stabilize the development or progression of a disease or skin condition. An exemplary skin condition is acne vulgaris
[00077] Qu Vgtoqu "eqorquVqu" g "ocVgtkcku" u"q wucfqu indifferently and refer to the active fractions according to the invention.
[00078] In this desctk>«q, “eqortggpfg,” “eqortggpfgpfq,” “eqpVgpfq” g “eqo” g ukoinctgu rqfgo Vgt q ukipkfíecfq fguetkVq rctc gngu kqvgpfgt fvg “fg” "knenuknfq," g ukoknctgu= "sug eqpukuVg guugpekcnogpVg go" qw "eqnukuVg guugpekcnogpVg" also has the meaning described in US patent law and the term is open-ended, allowing the presence of more than is quoted, provided the characteristics basic or unpublished of what is quoted are not altered by the presence of more than what is quoted, but exclude the modalities of the prior technology.
[00079] "FgVgeVat" tgfgtg is to identify the presence, absence or amount of the analyte to be detected.
[00080] Rqt “suanVkfafg gfgVkxc” gpVgpfg is the amount of one required to alleviate the symptoms of a disease with respect to an untreated patient. The effective amount of active compound(s) used to practice the present invention for therapeutic treatment of a disease varies depending on the manner of administration, age, body weight and general health of the individual. Finally, the doctor or veterinarian will decide the appropriate amount and dosage regimen. Such an amount is referred to as a swanVkfafg "gfgVkxa"
[00081] Rqt “aVkxa>«q rqt gngtika” gnVgnfg is stimulation by an energy source that causes thermal or chemical activity. Power activation can be by any power source known in the technology. Exemplary energy sources include a laser, ultrasound, acoustic source, flash lamp, ultraviolet light, an electromagnetic source, microwave or infrared light. A material that absorbs energy absorbs energy and becomes thermally or chemically active.
[00082] Qu Vgtmqu ‘light”, “gngtika numinqua”, “gngtika optical” g “tafka>«q optical” u«q uuafqu asuk knfkfgtgnVgmgnVgo
[00083] Fa fqtma asuk uuafa, "qdvgnfq" eqmq gm "qdvgndo an aignvg" knenuk uknvgvkzat, eqmrta qu fg quvta fqtma afsuktkt q aignvg0
[00084] C ftaug "eattgafqt fatmaeguVkeamgnVg aegkváxgn" fa fqtma asuk used means a pharmaceutically acceptable material, composition or vehicle, such as a liquid or solid filler, diluent, excipient, solvent or encapsulating material, involved in the carrying or transport of a material activatable by energy of the present invention in or to other individuals in such a way as to perform its intended function. Each carrier must be “cegkVáxgn” pq ugpVkfq fg ugt eqorcVíxgn eqo qu qwVtqu kPitgfkgpVgu fc formulation and not harmful to the patient. Some examples of materials that can serve as pharmaceutically acceptable carriers include: sugars such as lactose, glucose and sucrose; starches such as corn starch and potato starch; cellulose and its derivatives, such as sodium carboxymethyl cellulose, ethyl cellulose and cellulose acetate; powdered tragacanth; malt; gelatine; baby powder; excipients such as cocoa butter and suppository waxes; oils such as peanut oil, cottonseed oil, safflower oil, castor oil, olive oil, corn oil and soybean oil; glycols such as propylene glycol; polyols such as glycerin, sorbitol, mannitol and polyethylene glycol; esters such as ethyl oleate and ethyl laurate; agar; buffering agents such as magnesium hydroxide and aluminum hydroxide; alginic acid; pyrogen-free water; isotonic saline; Ringer's solution; ethyl alcohol; phosphate buffer solutions; and other non-toxic compatible substances employed in pharmaceutical formulations. Preferred carriers include those capable of entering a pore by surface action and solvent transport, such that the energy-activatable material is carried in or around the pore, for example, the sebaceous gland, the plug, the infundibular and/or in the sebaceous and infundibular glands.
[00085] Rqt “tgfwz” gpVgpfg if a negative change of at least 10%, 25%, 50%, 75% or 100%.
[00086] Rqt “tgfètêpekc” gpVgpfg if a standard or control condition.
[00087] Rqt "individual" gpVgpfg means a mammal including, but not limited to, a human or non-human mammal, such as a bovine, equine, canine, ovine or feline mammal.
[00088] Ranges provided here must be shorthand for all values in this range. For example, a range from 1 to 50 should include any number, combination of numbers, or subrange of the group consisting of 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14 , 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39 , 40, 41, 42, 43, 44, 45, 46, 47, 48, 49 or 50.
[00089] Fc hqtoc cswk wucfc. qu Vgtoqu “VtcVct,” VtcVcpfq.” "VtcVcogpVq." g ukoknctgu strives to reduce or alleviate a disorder and/or symptoms associated with it. It is understood that, while not excluded, the treatment of a disorder or condition does not require that the disorder, condition or symptoms associated with it be completely eliminated.
[00090] Although specifically established or obvious from the context, as used here, teq “qw” fexe uet kpenwukxqo Godqtc specifically established or obvious from the context, as here wucfc. qu vgtoqu “wo”. “woc”. “q” g “c” fgxgo ugt gpvgpfkfqu eqoq ukpiwnct or plural.
[00091] Although specifically stated or obvious from copvgzvq. fc hqtoc cswk wucfc. q vgtoq “egtec fg” fi gpvgpfkfq eqoq go woc tolerance of the normal range in technology, for example, in 2 standard deviations from the mean. About can be understood as in 10%, 9%, 8%, 7%, 6%, 5%, 4%, 3%, 2%, 1%, 0.5%, 0.1%, 0.05 % or 0.01% of the established value. Unless otherwise clear from the context, all numerical values provided herein are modified by the term about.
[00092] Citation of a listing of chemical groups in any definition of a variable here includes definitions of the variable as any single group or combination of the groups listed. Citation of an embodiment of a variable or aspect herein includes the embodiment as any single embodiment or in combination with any other embodiments or portions thereof.
[00093] Any compositions or methods provided herein may be combined with one or more of any of the other compositions and methods provided herein. Pathogenesis of follicular disease
[00094] Sebaceous glands are components of the polysebaceous unit. They are located throughout the body, especially on the face and upper torso, and produce sebum, a lipid-rich secretion that coats the hair and the epidermal surface. Sebaceous glands are involved in the pathogenesis of several diseases, the most frequent being acne vulgaris. Acne is a multifactorial disease characterized by the occlusion of follicles by plugs made up of abnormally lost keratinocytes from the infundibular (upper portion of the hair follicle) in the control of excess sebum production by overactive sebaceous glands.
[00095] The infundibular is an important site in the pathogenesis of many follicular diseases (eg acne). There is evidence that abnormal proliferation and desquamation of infundibular keratinocytes leads to the formation of microcomedones and, uwdugswgpVgogpVg. c “rnwiwgu” qw eqogfõgu fonkewnctgu clinically visible. Because infundibular architecture is important in the pathogenesis of acne, selective destruction of this portion of the follicle through energy-activated energy-assisted material, eg laser, bleaching eliminates or reduces the site of the pathology. Topical Dispensing of Light/Energy Absorbing Materials
[00096] The invention provides dispensing materials that absorb light/energy through topical administration in the skin appendages of the follicle, specifically infundibular follicular and sebaceous gland. In one embodiment, such materials are used for the treatment of follicular diseases such as acne (e.g. acne vulgaris), hyperhidrosis. The introduction of energy-activatable materials into the sebaceous glands followed by exposure to energy (light) with a wavelength that corresponds to the chromophore absorption peak will increase the local absorption of light into the tissue and lead to selective thermal damage to the sebaceous glands.
[00097] In another aspect, there is treatment of hyperhidrosis thermally damaging eccrine glands or their surrounding area by applying a material that absorbs light to an individual's skin, facilitating dispensing into an eccrine gland through the eccrine gland duct and exposing said material activation by energy. The method permanently removes the glands. In one aspect, the method of treating a follicular disease is for treating hyperhidrosis. Skin preparation
[00098] If desired, the skin is prepared by one or a combination of the following methods. Dispensing of light-absorbing material can be facilitated by hair removal, which is performed prior to topical administration of the light-absorbing material.
[00099] Optionally, the skin is degreased before applying the light-absorbing compounds. For example, acetone wipes are used before applying sebum peels to degrease the skin, especially to remove sebum and follicular contents.
[000100] For certain individuals, dispensing may be facilitated by reducing or cleaning collapsed follicles prior to application of light absorbing material. Such cleaning can improve the dispensing of nanoshells. Follicles, especially in acne-prone patients, are collapsed by lost keratinocytes, sebum, and P. Acnes bacteria. The follicle can be emptied by applying a vacuum. Other methods are cyanoacrylate stripping, strips with components such as Polyquaternium 37 (eg Biore pore stripping strips). Polymers flow into the follicle and dry over time. When the dry polymer film is removed, the follicular contents are removed, emptying the follicle.
[000101] Optionally, the skin can be heated prior to application of the light absorbing material. Heating reduces the viscosity of the tallow and can liquefy the tallow components. This can facilitate the delivery of light-absorbing material (eg, formulated as nanoshells) to the follicle. Topical Dispensing of Light Absorbing Material
[000102] Light absorbing materials such as non-toxic dyes (eg indocyanine green or methylene blue) are topically applied to the skin after any desired preparation. Topically applied formulations containing the light absorbing material may comprise ethanol, propylene glycol, surface active agents and acetone. Such additional components facilitate dispensing into the follicle.
[000103] Dispensing of light-absorbing material is facilitated by the application of mechanical agitation, such as massage, acoustic vibration in the range of 10 Hz - 20 kHz, ultrasound, alternating suction and pressure, and jets. In one embodiment, light-absorbing materials are dispensed as nanoparticles, such as nanoshells or nanorods that absorb light in the visible region and near the IR of the electromagnetic spectrum. In another embodiment, light-absorbing materials are quantum dots. Preferably, the light absorbing materials are formulated for topical dispensing in a form that facilitates follicular dispensing. In one embodiment, such formulations comprise water, ethanol, isopropyl alcohol, propylene glycol, surface active agents and isopropyl adipate and related compounds. In one embodiment, the formulation is hydrophilic and contains a surface-active agent. In another embodiment, the formulation is lipophilic and contains a surface-active agent. In yet another embodiment, the composition is liposomal and contains a surface-active agent. In any of the above embodiments, the surfactant is less than 10% of the formulation. In another embodiment, the formulation is hydrophilic. In yet another embodiment, the formulation is lipophilic. In yet another embodiment, the composition is liposomal. Ultrasound-facilitated dispensing
[000104] Ultrasound has been used to obtain transdermal delivery of compounds into the body. Ultrasound appears to generate shock waves and micro-jets that result from bubble cavitation that causes channels to form in the skin, which provide transport of the molecules of interest. Previous efforts have been directed towards dispensing the compounds through the stratum corneum. Small molecules, for example, with sizes smaller than 5 nm, can be dispensed through the stratum corneum. The dispensing rate through the stratum corneum drops significantly as particle size increases. For example, for particles with a size of 50 nm and above, the dispensing rate through the stratum corneum is very low. However, this size is still much smaller than the opening of the pore and infundibular of a follicle. For example, 150 nm sized silica core and gold shell structures are used that are much smaller than the infundibular diameter, while at the same time showing low skin deposition across the stratum corneum.
[000105] These findings provide the basis of acne treatment, in which the sebaceous unit of the infundibulum is selectively targeted to first dispense appropriately sized light absorbing material and then selective thermal damage to the unit with pulsed laser irradiation. Here, ultrasound specifically facilitates the dispensing of a light-absorbing material into the follicular structure. Shock waves, micro-jet formation, and vaporization distribute the light-absorbing particles into the follicular infundibular and associated sebaceous gland duct and sebaceous gland.
[000106] Ultrasound is often accompanied by heating of the target organ, skin. Some heating, for example, up to about 42°C can help with follicular dispensing. However, excessive heating is undesirable, causing pain, tissue damage, and burns. In one modality, excessive heating can be avoided by cooling the skin, for example. In another embodiment, the topically applied formulation or a coupling gel can be pre-cooled or cooled in parallel. A low rate cycle with repeated ultrasound pulse burns can also be used to prevent excessive heating, where during the off time the body cools the skin that is subjected to ultrasound energy.
[000107] In certain embodiments, the invention provides two methods of dispensing ultrasound. Wo fi "wnvtcuuqo fg eqpVcVq" g wo qwVtq fi "wnvtcuuqo fg kogtu«q"
[000108] According to an embodiment of the contact ultrasound method, a formulation of the invention is topically applied to the skin by spreading in a thin layer and a sound signal that vibrates at an ultrasound frequency is placed in close contact with the skin covered by the formulation .
[000109] According to a modality of the immersion ultrasound method, a reservoir filled with the formulation is placed on top of the skin, a sound signal is submerged in it without the sound signal touching the skin at a distance ranging from about 2 mm to about 30 mm and the beep then vibrates at the ultrasound frequency.
[000110] Acoustic cavitation is often an effect seen with ultrasound in liquids. In acoustic cavitation, a sound wave imposes a sinusoidally varying pressure on the existing cavities in uqnw>«qo FwtcpVg q ekenq fg rtguu«q pgicVkxq. q níswkfq fi ugrctcfq pqu òrqpVqu htcequÓ0 Vcku rqpvqu htcequ rqfgo ugt vcpvq dqnjcu rtfi-existing as solid nucleation sites. In one modality, a bubble is formed that grows until it reaches a critical zone known as its resonance size (Leong et al., Acoustics Australia, 2011 - acoustics.asn.au, THE FUNDAMENTALS OF POWER ULTRASOUND-A REVIEW, p 54 -63). According to Mitragotri (Biophys J. 2003; 85(6): 3502-3512), the spherical collapse of bubbles yields high-pressure nuclei that emit shock waves with amplitudes exceeding 10 kbar (Pecha and Gompf, Phys. Rev. Lett. 2000; 84:1328-1330). Also, an aspheric collapse of bubbles near the edges, such as skin, yields microjets with velocities on the order of 100 m/s (Popinet and Zaleski, 2002; J. Fluido. Mech. 464:137-163). Such blister collapse phenomenon can aid in dispensing materials in skin appendages, such as hair and sebaceous follicles. Thus, various embodiments of the invention provide immersion ultrasound methods for optimizing bubble size before collapse to promote efficient dispensing of light absorbing material to the intended target (e.g., sebaceous glands, hair follicles).
[000111] The bubble's resonance size depends on the frequency used to generate the bubble. A simple, approximate relationship between resonance and bubble diameter is given by F (in Hz) x D (in m) = 6 mHz, where F is the frequency in Hz and D is the bubble diameter (size) in m . In practice, the diameter is usually smaller than the diameter predicted by this equation due to the non-linear nature of the bubble's pulsation.
[000112] Table 1 below gives the bubble resonance size as a function of frequency, calculated from the above ratio. Table 1

[000113] Computer simulations of the bubble oscillations give more accurate estimates of the bubble size. For example, in the work of Yasui (J. Acoust. Soc. Am. 2002; 112: 1405-1413), three frequencies were investigated in depth. The sizes for stable bubbles in single-bubble sonoluminescence (SBSL) are lower and ranges are given in table 2 below (estimated from figures 1, 2 and 3 of Yasui, 2002): Table 2

[000114] For efficient dispensing in follicles with cavitation bubbles, there is an ideal cavitation bubble size range. Strong cavitational shock waves are needed, which are generated with relatively large bubbles. However, if the size of the blister is too large, it will produce strong shock waves, which can compress the skin, reducing pore size and reducing efficient delivery to a target (eg, sebaceous gland, follicle). For example, if the size of the blister is much larger than the opening of the follicle, the resulting shock waves will compress not only the opening of the pore, but also the skin surrounding the opening of the pore. This inhibits efficient dispensing in opening the follicle. Desirably, the size of the bubbles should be about the same size as the target pore. Typical pore sizes of follicles in human skin are estimated to be in the range of 12 - 300 microns. Thus, an advantageous ultrasound frequency range is 20 kHz to 500 kHz. In other alternatives, the ultrasound frequency application is in the range of 20 kHz to 100 kHz or 20 kHz to 60 kHz or even 30 kHz to 50 kHz. Desired power density is estimated in the range of 0.5 - 50 W/cm2-. This is enough to generate cavitation bubbles in the desired size range.
[000115] "EcxkVc>«q rqt kogtu«q", fc fotoc cswk wucfc, fi fgfipkfc as formation and collapse of cavitation bubbles due to ultrasound energy in the fluid formulation.
[000116] In light of the foregoing description, a method of facilitating the dispensing of light-absorbing material into a hair follicle is also provided by selecting characteristics for the acoustically created micro-jets to create bubbles in the formulation of about the same size as the hair follicle pore . The selection of characteristics allows the blisters to be about the same size as a terminal follicle, a villous follicle, or a sebaceous follicle. In another alternative implementation in light of the foregoing description, a method of facilitating the dispensing of light-absorbing material into a hair follicle is also provided by selecting characteristics for low-frequency ultrasound-induced cavitation to create bubbles in the fence formulation. same size as the hair follicle. In one implementation, the hair follicle is a terminal follicle. In another implementation, the hair follicle is a villous follicle. In yet another implementation, the hair follicle is a sebaceous follicle. In still other aspects ultrasound-created micro-jets or low-frequency ultrasound-induced cavitation occur in the formulation at between about 50 microns to about 100 microns from the skin surface.
[000117] In another embodiment, a method of treating or alleviating a follicular skin disease of an individual is also provided. The method includes the step of exposing the subject's skin to a formulation comprising a submicron particle comprising a material that absorbs light on the subject's skin. Then there is a step of facilitating the dispensing of said skin material into a hair follicle by low-frequency ultrasound-induced cavitation in the formulation close to the skin surface adjacent to the hair follicle. Thereafter, expose said submicron particle to energy activation, thus treating follicular skin disease. In an alternative, there is also an exposure step by placing a volume of the formulation in a container such that the formulation is in contact with the individual's skin. Still additionally, there is also a step of facilitating the method by placing an ultrasound applicator in the container and submerged in the formulation.
[000118] In yet another embodiment, a method of facilitating the dispensing of a material that absorbs light to a target volume on an individual's skin is provided. The method includes the step of topically applying a formulation comprising a material that absorbs light to the subject's skin to deliver the material to a reservoir in the target skin volume. There is then a step of facilitating dispensing said material to a target volume on the individual's skin substantially through a transfollicular path. Then there is a step of exposing the light-absorbing material to a series of light pulses to heat the material and thermally damage the target volume to achieve a therapeutic effect. In an alternative, the formulation has an optical density between 5-500. In yet another alternative, the formulation has an optical density of about 75. In yet another alternative, the formulation has an optical density of about 125. In yet another alternative, the formulation has an optical density of about 250. In one aspect, the target volume is the sebaceous gland. In another aspect, the target volume is in the follicle below the skin.
[000119] In yet another aspect, the facilitating step includes a step of cavitation by immersion. In another alternative, a step of facilitating dispensing into a sebaceous gland using immersion ultrasound is provided. In an alternative, the facilitating step includes forming micro-jets in the formulation. In one aspect, facilitation using ultrasound produces cavitation in a formulation and about 50 to 100 microns from the skin surface. In any of the methods described, there is also the step of acoustically cavitating the formulation to selectively facilitate the dispensing of said particles in the formulation into a sebaceous gland primarily via the corresponding hair follicle. Thereafter, there is the step of irradiating said particles with light to treat the follicular skin disease. In one embodiment, particles are rated from about 1 micron to about 5 microns. In another aspect, particles are classified with respect to the entrance to and along a pore of the follicle. In yet other embodiments, the particles are between about 50 nm to about 250 nm in diameter. In another embodiment, the particles are nanoshells. Activation by energy (light)
[000120] After topical administration and facilitated dispensing (eg by mechanical agitation, ultrasound), the top of the skin is cleaned to remove residual light-absorbing material. this is followed by irradiation of energy (light). Light is absorbed by material within the follicle or sebaceous gland, leading to localized heating. The light source depends on the absorber used. For example, for nanoshells that have broad absorption spectrum at 800 nm resonance wavelength, light sources such as 800-nm, 755-nm, 1064-nm, or intense pulsed light (IPL) with appropriate filtration, can be used. In one aspect, nanoparticles in a suspension have an absorption peak between 700 and 1100 nm wavelength of light. Such pulsed laser irradiation leads to thermal damage to the tissue surrounding the material. In one aspect, light energy has a fluence of less than about 100 J/cm2. Infundibular follicular stem cell and/or sebaceous gland damage leads to improvement in follicular conditions such as acne. Such methods can be used not only for particulates in suspensions, but for small molecules equally dissolved in solution. These may include pharmaceutical drugs, photodynamic therapy (PDT) prodrugs or PDT drugs.
[000121] Suitable energy sources include light-emitting diodes, incandescent lamps, xenon arc lamps, lasers or sunlight. Suitable examples of continuous wave apparatus include, for example, diodes. Suitable flash lamps include, for example, pulse dye lasers and Alexandrite lasers. Representative lasers with wavelengths strongly absorbed by chromophores, eg laser sensitive dyes, in the epidermis and infundibular but not in the sebaceous gland, include the short pulse red dye laser (504 and 510 nm), the vapor laser of copper (511 nm) and the Q-pressed (Nd):YAG neodymmium laser with a wavelength of 1064 nm which can also be dual frequency using a potassium diphosphate crystal to produce visible green light with one wavelength of 532 nm. In the present process, selective photoactivation is employed, while an energy source (light), eg, a laser, is combined with a wavelength for the absorption spectrum of the selected energy-activatable material, preferably a chromophoric agent.
[000122] It is easier to obtain a high concentration of light absorbing material in the infundibular than the sebaceous duct and gland, which provides greater resistance to material transport. The follicle, including the sebaceous gland, can be irreversibly damaged only being responsible for light absorption mainly, but the material in the infundibular. This is mediated through damage to keratinocytes in the follicular epithelium. Also, with greater energy, pulses can be used to extend thermal damage to include stem cells in the outer root bark, swelling, as well as in the outer periphery of the sebaceous glands. However, such high energy should not lead to unwanted side effects. Such side effects can be lessened by the use of epidermal cooling and also the use of longer pulse durations, on the order of several milliseconds, extending up to 1000 ms.
[000123] Thermal alteration of the infundibular itself with only limited involvement of the sebaceous glands can improve acne. Appearance of enlarged pores on the face is a common problem for many. This is typically due to enlarged sebaceous glands, enlarged infundibular as well as enlarged pore opening. Heating the tissue, especially collagen, shrinks the tissue. Dispensing nanoshells and thermally bleaching them without the sebaceous unit of the infundibulum, which includes the superior and inferior infundibular as well as the sebaceous gland, will improve the appearance of enlarged pores. Material formulations that absorb energy
[000124] The invention provides compositions comprising light/energy absorbing materials for topical dispensing. In one embodiment, a particle in the composition is a nanoparticle comprising a silica core and a gold shell. In yet another embodiment, a compound of the invention comprises a silica core and a gold shell (150 nm). In another embodiment, used nanoshells are composed of a 120 nm diameter silica core with a 15 micron thick gold shell, giving a total diameter of 150 nm. The nanoshell is covered with a layer of 5,000 MW PEG. Each of PEG prevents and/or reduces nanoshell aggregation, thus increasing the stability and shelf life of nanoshell suspensions. In one embodiment, the nanoparticle has a diameter of about 50 to about 250 nm. In some embodiments, the ratio of shell diameter to core diameter of the particles as used herein is between about 1.5 to about 2.0. In another aspect, particles in a formulation comprise from about 0.5% to about 2% of the formulation.
[000125] Nanoparticles of the invention exhibit surface plasmon resonance, in such a way that incident light induces the optical resonance of surface plasmons (oscillating electrons) in the metal. The coortkogpVq fg qpfc fq rkeq fg cduqt>«q rqfg ugt “cfmcfq” pc rqt>«q fq infrared (IR) of the electromagnetic spectrum. The submicron size of these nanoparticles allows their entry into the infundibular, sebaceous duct and sebaceous gland of the epidermis and minimizes their penetration of the stratum corneum. In a particular embodiment, selective transfollicular penetration of nanoparticles ~150-350 nm in diameter is obtained. In one aspect, a method of treating or alleviating an individual's follicular skin disease is provided. There is a step of topically applying a formulation comprising a submicron particle comprising a material that absorbs light to the individual's skin. There is then a step of dispensing said formulation into one or more sebaceous glands, substantially via a transfollicular pathway. Then there is a step of exposing said submicron particle to energy activation, thus treating the follicular skin disease. In one aspect, a portion of the stratum corneum in the portion of skin exposed to the dispensing step remains intact. Still further, the dispensing step is completed using an immersion ultrasound step, while the portion of the stratum corneum in the portion of skin exposed to the dispensing step remains intact.
[000126] If desired, light/energy absorbing materials are provided in vehicles formulated for topical dispensing. In one embodiment, a composition of the invention is formulated with agents that improve follicular dispensing including, but not limited to, one or more of ethanol, isopropyl alcohol, propylene glycols, surface active agents such as polysorbate 80, Phospholipon 90, polyethylene glycol 400, and isopropyl adipate. In other embodiments, a composition of the invention is formulated with one or more thickening agents including, but not limited to, hydroxypropyl cellulose (HPC) and carboxymethyl cellulose (CMC), to improve the handling of the formulations.
[000127] Wetting agents, emulsifiers and lubricants such as sodium lauryl sulfate and magnesium stearate, as well as coloring agents, release agents, coating agents, sweetening and perfuming agents, preservatives and antioxidants can also be present in the compositions.
[000128] Liquid dosage forms for topical administration of the compositions of the invention include pharmaceutically acceptable emulsions, microemulsions, solutions, creams, lotions, ointments, suspensions and syrups. In addition to the active ingredient, liquid dosage forms may contain inert diluents commonly used in technology, such as, for example, water or other solvents, solubilizing agents and emulsifiers, such as ethyl alcohol, isopropyl alcohol, ethyl carbonate, ethyl acetate , benzyl alcohol, benzyl benzoate, propylene glycol, 1,3-butylene glycol, oils (in particular, cottonseed, peanut, corn, germ, olive, castor, peach, almond and sesame oils), glycerol, tetrahydrofuryl alcohol , polyethylene glycols and sorbitan fatty acid esters and mixtures thereof.
[000129] Suspensions, in addition to the active compounds, may contain suspending agents such as ethoxylated isostearyl alcohols, polyoxyethylene sorbitol and sorbitan esters, microcrystalline cellulose, aluminum meta-hydroxide, bentonite, agar-agar and tragacanth and mixtures thereof .
[000130] Ointments, pastes, creams and gels may contain, in addition to an active compound of this invention, excipients such as animal and vegetable fats, oils, waxes, paraffins, starch, tragacanth, cellulose derivatives, polyethylene glycols, silicones, bentonites, silicic acid, talc and zinc oxide qw okuVwtcu fguVgUo Q Vgtoq “etgog” fi tgeqpjgekfq nc Vgenqnqikc g fgxg include semi-solid emulsion systems that contain both an oil and water. Oil-in-water creams are miscible with water and are well absorbed into the skin, aqueous BP cream. Water-in-oil (oily) creams are immiscible with water and therefore more difficult to remove from the skin. These creams are emollients, lubricates and moisturizes eg oily BP cream. Both systems require the addition of a natural or synthetic surface-active agent or emulsifier.
[000131] Q vgtoq “wpiwgpvq” fi tgeqpjgekfq pc vgepqnqikc g fgxg kpenwkt systems that have oil or grease as their continuous phase. Ointments are semi-solid anhydrous substances and are occlusive, emollient and protective. Ointments restrict transepidermal water loss and are thus moisturizing and moisturizing. Ointments can be divided into two main fatty groups, eg soft white paraffin (petrolate, Vaseline) and water soluble eg Macrogol (polyethylene glycol) Ointment BP. The Vgtoq “nq>«q” fi tgeqpjgekfq nc Vgenqnqikc g fgxg knenwkt cu uqnw>õgu VkrkecognVg wucfcu go crnkec>õgu fgtocVqn„ikecUo Q Vgtoq “igni” of high molecular weight allowed gels should include high molecular weight gels if recognized in the technology for example, carboxypolymethylene (Carbomer BP) or methylcellulose, and may be listed as semiplastic aqueous lotions. They are typically non-wax, miscible with water, easy to apply and wash, and are especially suitable for treating hair parts of the body. monitoring of the individual
[000132] The disease state or treatment of an individual with a skin disease or disorder can be monitored during treatment with a composition or method of the invention. Such monitoring can be used, for example, in estimating the effectiveness of a particular agent or treatment regimen in a patient. Therapies that promote skin health or improve the appearance of skin are considered particularly useful in the invention. cases
[000133] The invention provides kits for the treatment or prevention of a skin disease or disorder or symptoms thereof. In one embodiment, the kit includes a pharmaceutical package comprising an effective amount of a light/energy absorbing material (eg, a nanoshell with a silica core and a gold shell (150nm)). Preferably, the compositions are presented in unit dosage form. In some embodiments, the kit comprises a sterile container that contains a therapeutic or prophylactic composition; such containers may be boxes, ampoules, bottles, vials, tubes, bags, pouches, ampoule packs or other suitable container forms known in the art. Such containers can be made of plastic, glass, laminated paper, sheet metal or other materials suitable for holding the medications.
[000134] If desired, compositions of the invention, or combinations thereof, are provided along with instructions for administering them to an individual with or at risk of developing a skin disease or disorder. Instructions will generally include information regarding the use of the compositions for treating or preventing a skin disease or disorder. In other embodiments, instructions include at least one of the following: describing the compound or combination of compounds; dosage and administration schedule for the treatment of a skin condition associated with acne, dermatitis, psoriasis or any other skin condition characterized by inflammation or a bacterial infection or symptoms thereof; precautions; warnings; indications; contraindications; overdose information; Adverse reactions; animal pharmacology; clinical studies; and/or references. Instructions can be printed directly on the container (when present) or as a label applied to the container or as a separate sheet, pamphlet, card or leaflet provided on or with the container.
[000135] Citation of a list of chemical groups in any definition of a variable here includes definitions of the variable as any single group or combination of the groups listed. Citation of an embodiment for a variable or aspect herein includes the embodiment as any single embodiment or in combination with any other embodiments or portions thereof.
[000136] The following examples are provided to illustrate the invention, not limit it. Those skilled in the art will understand that the specific constructs provided below can be altered in a number of ways, consistent with the invention described above, while retaining the critical properties of the compounds or combinations thereof. Laser Hair Removal
[000137] The invention features compositions and methods that are used for laser hair removal, particularly in light colored hair. In laser hair removal, a specific light wavelength and pulse duration are used to achieve an optimal effect on a bleached tissue with minimal effect on the surrounding tissue. Lasers can cause localized damage to a hair follicle by selectively heating melanin, which is a dark target material, while not heating the rest of the skin. Because the laser targets melanin, light colored hair, fine gray hair or fine hair, which have reduced levels of melanin, are not effectively targeted by existing laser hair removal methods. There are efforts to dispense various light-absorbing materials such as carbon particles, squid ink extracts, commercially known as meladin, or dyes in the follicle. These methods were very inefficient.
[000138] The present invention provides microparticles in a suspension form that is topically applied after skin preparation as outlined hereinbefore. In particular, the skin is prepared for hair shaft depilation and light absorbing materials are dispensed into the hair follicle. Preferably, the formulation is optimized for follicular dispensing with mechanical agitation over a period of time. After cleaning the formulation from the top of the skin, laser irradiation is carried out, preferably with surface cooling. The laser is pulsed, with a pulse duration of approximately 0.5 ms - 400 ms or alternatively 0.5 ms - 1000 ms using a wavelength that is absorbed by the particle or nanoshells. This method will permanently remove unpigmented or lightly pigmented hair by destroying the stem cells and other hair growth apparatus that reside in the swelling and bulb area of the follicle.
[000139] The practice of the present invention employs, unless otherwise indicated, conventional techniques of molecular biology (including recombinant techniques), microbiology, cell biology, biochemistry and immunology, which are well within the purview of those skilled in the art. Such techniques are gzrnkecfcu eqorngVcogpVg pc nkVgtcVwtc. Vcku eqq. “Ooneewncr Enopkpi< C NcdqtcVqt{ OcpwcF’. ugiwpfc gfk>«q *Ucodtqqm. 3;:;+= “QnkiopweneoVkfe U{pVjguku” *IckV. 3;:6+= "Animal Egnn Ewnvwtg” *Htgujpg{. 3;:9+= “OeVjofu kp Gnz{oqnqi{” "Handbook qh GzrgtkogpVcn Koowpqnqi{” *Yekr. 3;;8+= “Igpg Vtcpufet XgeVqtu for Ocmiferokcp Egnnu” (Miller and Calos, 1987); “EwrrepV RroVoeonu kp Ooneewncr Dkonogy” *Cwuwden. 3;:7+= “RET< Vje Ronkoercue Ejckp TeceVkop”, *Ownnku. 3;;6+= "EwrrepV RroVoeonu kp Koowponoi{" *Eonkicp, 3;;3+o GuVcu Vfiepkecu u"o crnkeáxeku § rrofw>"o fou polynucleotides and polypeptides of the invention and, as such, can be considered in the preparation and practice of the invention. Techniques particularly used for particular modalities will be discussed in the sections that follow.
[000140] The following examples are purported to provide those skilled in the art with a full disclosure and description of how to prepare and use the testing, selection and therapeutic methods of the invention and should not be limited by the scope of what the inventors relate to as his invention. EXAMPLES Example 1: Topical dispensing of nanoshells on follicular epithelium for the treatment of follicular diseases
[000141] An example of massage as a mechanical means of follicular dispensing is described. 800-nm thinned nanoshell suspension was massaged into a shaved pig in a live pig in vivo. Parallel contact-cooled laser energy was applied after cleaning the suspension on top of the skin. A biopsy was taken and routine histology performed. A micrograph of the histology is shown in Figure 1. Thermal damage to the follicular epithelium and part of the sebaceous gland is not noticed. Such damage is used to treat follicular diseases such as acne or to improve the appearance of an individual's oily skin.
[000142] An exemplary method for the above treatments includes the step of topically applying a formulation comprising a submicron particle comprising a material that absorbs light to the individual's skin. Then, there is a step to facilitate the dispensing of said materials to a hair follicle, sebaceous gland, sebaceous gland or infundibular skin duct by mechanical agitation, acoustic vibration, ultrasound, alternating suction and pressure or micro-jets. Thereafter, there is the step of exposing said submicron particle to energy activation, thus treating the follicular skin disease. Example 2: Topical dispensing of nanoshells on follicular epithelium for laser hair removal
[000143] In preparation for laser hair removal, one side of the pig was waxed. Skin was subsequently heated and a vacuum was applied to deflate the skin follicular contents. Silica core: Gold shell microparticles approximately 0.150 micrometers in diameter coated with PEG were then dispensed by massage. Skin has been cleaned to remove material from the top of the skin. This was followed by pulsed laser irradiation at 800 nm. Samples were taken, fixed in formalin and processed by routine histology (H&E stain). Thermal damage to the follicular structure was noted through histology. Example 3: Dispensing facilitated by pulse of pressure induced by pulse of light
[000144] A formulation containing a light absorbing material is applied to the top of the skin. This is moved in the infundibular of the sebaceous unit of the infundibulum by methods known in the art including, but not limited to, passive diffusion, heating, mechanical assistance, such as pressure pulse, vibration, acoustic cores, ultrasound, nozzles or a combination of the foregoing. Then, pulses of light are applied with a handpiece with an integrated cooling plate that can be pressed into the top of the skin. The first pulse(s) of light heats the material, resulting in expansion, with or without vapor bubble formation. A pressure pulse is thus created. Pressure is applied to the skin by the plate during the pressure pulse. Because pressure cannot escape the skin, material flows through low resistance channels in the skin, such as the sebaceous gland duct, to reach the sebaceous gland. This pulse typically has short pulse duration, eg 1 ns - 1 ms, preferably 10 ns - 100 microseconds, to maximize pressure pulse amplitude, eg through vapor bubble formation. Once the material is at the target sebaceous gland, light is applied with a pulse duration and radiant exposure appropriate to the size of the targeted sebaceous glands. The light-absorbing material is heated, causing thermal damage to the sebaceous gland, thereby inactivating it and causing improvement in acne vulgaris and other follicular diseases and conditions associated with the presence or activity of the sebaceous glands.
[000145] In a related approach, a train of low energy laser pulses, 1 microsecond or less in pulse duration, preferably in the acoustic range for pulse repetition rate, is used to cVkxct cu rcrtíewncUo GuVc aVkxa>«q xkqngpVcogpVg 'agita' cu rartíewnau, cniwocu from which they will be driven from the infundibular in the sebaceous glands. Example 4: Using ultrasound to dispense light-absorbing material into the follicle and sebaceous glands
[000146] Pig ear skin was kept frozen. Before the experiment, it was thawed. Hair was waxed and a piece of the pig's ear with the skin up was placed in the base of a cup. It was filled with a 150-nm diameter silica core/gold shell nanoshell formulation (Sebacia, Inc., Duluth, GA) with an optical density of approximately 250. A Sonics beep device, 20 kHz was submerged in the formulation. , in such a way that the distance between the surface farthest from the sound signal at the top of the skin was approximately 5-mm. The diameter of the beep was 13 mm and the power output was approximately 6 W. Thus, the power density during on-time was 4.5 W/cm2. The device was turned on with a 50% duty cycle, with the on time and off time per cycle of 5s and 5s, respectively. Four cycles were applied. After cleansing the skin to remove excess formulation, the skin was irradiated with laser light at 800-m wavelength with a 9 mm x 9 mm spot, approximately 50 J/cm2 total radiant exposure and pulse duration 30 -ms.
[000147] The skin was observed using a dissecting microscope and photographs were taken (Figure 2). Cuts perpendicular to the skin surface were made through the opening of the follicles and the cut surface was observed under an optical microscope (Figure 3). Some samples were placed in a 10% buffered formalin solution and observed by routine histology (Figure 4).
[000148] The skin was intact and undisturbed, except that dotted spots were noted at the opening of the follicles (Figure 2). Upon sectioning and observation under a microscope, the presence of dark nanoshells was noted in the infundibular follicle, as well as in the sebaceous glands (Figure 3). No nanoshells were seen in the epidermis or in the dermis surrounding the follicles. Similarly, histology showed thermal damage to the follicular infundibular and sebaceous glands (Figure 4). There was no or minimal damage to the epidermis and dermis surrounding the follicles.
[000149] In an alternative aspect, in a method employing an ultrasound audible signal used for immersion ultrasound, the peak-to-peak amplitude shift of the ultrasound audible alarm face is in the range of 0.5 to 30 microns .
[000150] In still other aspects, a selected submicron particle size with respect to passage in the hair follicle and a sebaceous gland of the hair follicle is provided. In one embodiment, the hair follicle is a terminal follicle. In another modality, the hair follicle is a villous follicle. In yet another modality, the hair follicle is a sebaceous follicle. In still further implementations of the inventive methods described herein, the submicron particle size is between about 0.01 microns to about 1.0 microns. In yet another exemplary implementation, the submicron particle size is between about 0.05 to about 0.25 microns. Example 5: Ultrasound-facilitated dispensing
[000151] An APC International of Mackeyville, PA transducer was driven by a 300 Vp-p sine wave from a waveform generator and an amplifier with 500 Ohm source impedance. A 250 OD formulation (F78, Sebacia, Inc.) containing the silica core: 150 nm diameter gold shell was placed topically on the shaved pig's ear skin. This was followed by top surface cleaning and laser irradiation with Lumenis Lightsheer at 800 nm. Skin temperature was noted after ultrasound application and did not exceed 41°C.
[000152] Significant accumulation of nanoshells in the follicles was noted (Figure 5). Vertical cuts were made through the follicles and the cut surfaces were observed under a microscope. An exemplary follicle is shown in Figure 6. A significant accumulation of nanoshells inside and outside the infundibular is noted.
[000153] Histological analysis of a sample is shown in Figure 7. Localized thermal damage to the follicle including thermal damage to the sebaceous glands is observed (Figure 7). Example 6: Human clinical efficacy demonstrated in black acne
[000154] Topical dispensing of nanopeel efficacy followed by laser treatment was evaluated in a clinical study of black acne. Nanoshells were topically applied to each subject's back and laser treatment was initiated as described above. This treatment regimen was administered twice to each subject. Results were evaluated twelve weeks after the second treatment. Efficacy was determined by heavy inflammatory lesion counts. Results are shown in Figure 8. This study of black acne indicates that the treatment regimen was clinically effective. Example 7: Human clinical efficacy demonstrated in sebaceous gland damage
[000155] IRB-approved human clinical studies were performed in seventeen subjects (6 males, 11 females) with acne. Individuals range in phototype I-IV from age 18-40 years (mean 24 years). Treatment was carried out on a 1-inch square area behind the ear (sebaceous follicles). Nanoshells were dispensed followed by laser treatment, where the laser was tuned to the nanoshell absorption peak (40-50 J/cm2, 30-ms, 9 x 9 mm, LightSheer (800 nm)). Therapeutic efficacy was evaluated histologically in 31 biopsies, where 4-7 follicles were present in each biopsy. A 4-mm puncture biopsy was serially related and damage to the sebaceous follicle was visualized by H&E staining. Pain, erythema, minimal edema. Localized damage was observed in ~60% of sebaceous follicles. In some samples, destruction of the entire sebaceous gland was observed. The depth of thermal damage in the follicles was on average 0.47 mm (maximum 1.43 mm). No collateral damage to the epidermis or dermis was observed. Histology study of in vivo damage in the infundibular, swelling and sebaceous glands was observed after treatment. Example 8: Ultrasound-facilitated dispensing of photodynamic therapy (PDT) with aminolevulinic acid (ALA)
[000156] In ultrasound experiments, the follicle provided easier access for dispensing light-absorbing material than the stratum corneum. This may be due to a differential in transport rates in the stratum corneum and follicle. This difference can be explained to facilitate selective dispensing of smaller molecules. This approach can be used for either chromophores in a photothermal treatment regimen or for photodynamic therapy with compounds or prodrugs that lead to the photodynamic effect. For example, convention acne therapies involving ALA-PDT treatment require long incubation times (on the order of 3-4 hours) to deliver sufficient concentration of ALA into the sebaceous glands to obtain the desired clinical efficacy.
[000157] This treatment results in significant adverse side effects, including long-term epidermal crusting, pain and redness. This extended incubation period results in the dispensing of ALA into non-target areas of the epidermis and dermis. Ultrasound-assisted dispensing can be performed without these long incubation periods, while still achieving sufficient concentrations in the sebaceous unit of the target infundibulum. Because the long incubation period is eliminated with ultrasound dispensing, little ALA is dispensed into the non-target epidermis and dermis. After ultrasound dispensing, the ALA formulation can be removed from the skin surface. Light irradiation is carried out once sufficient time has elapsed to ensure that photoactive material concentrations have reached adequate levels in the target volume. In photothermal treatments, pulsed laser irradiation can be started shortly after dispensing.
[000158] In another modality, materials (compounds) of interest are attached to the microparticles and dispensed to the target volume. Light irradiation can be used to dissociate the material, leading to its diffusion and subsequent action. Formation of cavitation bubbles is facilitated by the presence fg pcnqrcrtiewncu swg “ugogkco” c fotoc>«q fg dqnjCo Vcodfio. Dispensing can be facilitated by the use of volatile components such as ethanol. Example 9: Formulations
[000159] Several nanoshell formulations were tested in an ex vivo skin model. The tested components were designed to improve dispensing into the follicles. Formulation constituents were ethanol, isopropyl alcohol, propylene glycols, surface active agents such as polysorbate 80, Phospholipon 90, polyethylene glycol 400, isopropyl adipate. Compatibility of these against each other was tested. Three classes were identified: hydrophilic, lipophilic and liposomal. The absorption coefficient of the formulation is suggested as in the range of 10 to 1000 cm inverse. Four example formulations were tested in an in vivo pigskin model; the compositions are as in table 3 below which shows four of the formulations tested in a human black acne study. Table 3
Other modalities
[000160] From the foregoing description, it will be evident that variations and modifications can be made to the invention described herein to adopt it in various uses and conditions. Such modalities are also within the scope of the following claims.
[000161] Citing a list of elements in any definition of a variable here includes definitions of the variable as any single element or combination (or subcombination) of the listed elements. Citation of an embodiment herein includes the embodiment as any single embodiment or in combination with any other embodiments or portions thereof. Incorporation by reference
[000162] This patent application includes subject matter which may be related to subject matter described in USSN 12/787,655, US Patent Application No. 2012/0059307 and US Patent No. 6,183,773, each of which is hereby incorporated by reference in its entirety. All patents and patent applications mentioned in this specification are hereby incorporated by reference at the same point, as if each patent and independent patent application were specifically and individually indicated to be incorporated by reference.

权利要求:
Claims (21)
[0001]
1. Use of a light-absorbing material, characterized in that it is in the manufacture of a composition to treat or alleviate a follicular skin disease, to improve the appearance of skin, or to inhibit hair growth in an individual, where the light-absorbing material is topically applied to a skin surface; the light-absorbing material is dispensed into one or more selected from the group consisting of: a hair follicle, a sebaceous gland, a sebaceous gland duct, and an infundibular; and light-absorbing material is exposed to activation by energy.
[0002]
2. A method of improving the appearance of the skin or inhibiting hair growth in an individual, characterized in that the method comprises: topically applying a light-absorbing material to the surface of the individual's skin; facilitate the dispensing of light-absorbing material to one or more selected from the group consisting of: a hair follicle, a sebaceous gland, a sebaceous gland duct, or an infundibular; and exposing light-absorbing material to activation by energy.
[0003]
3. Use according to claim 1 or the method of claim 2, characterized in that the appearance of oily skin is improved.
[0004]
4. Use according to claim 1 or the method according to claim 2, characterized in that the appearance of enlarged pores in the skin is improved.
[0005]
5. Use according to claim 1 or the method according to claim 2, characterized in that the growth of lightly pigmented or fine hair is inhibited.
[0006]
6. Use according to claim 1 or the method of claim 2, characterized in that: the energy comprises light; and the light-absorbing material therefore emits heat.
[0007]
7. Use according to claim 1 or the method of claim 2, characterized in that the energy is light energy having a wavelength that is preferentially absorbed by the light-absorbing material.
[0008]
8. Use according to claim 1 or the method of claim 2, characterized in that the light-absorbing material is removed from the individual's skin surface prior to the exposure step.
[0009]
9. Use according to claim 1 or the method of claim 2, characterized in that the skin is prepared before the application step by one or more selected from the following group consisting of: heating, removal of follicular contents, and depilation .
[0010]
10. Use according to claim 1 or the method of claim 2, characterized in that the skin is heated to a temperature between 40°C to 44°C.
[0011]
11. Use according to claim 1 or the method of claim 2, characterized in that the light-absorbing material is a plurality of submicron particles.
[0012]
12. Use according to claim 1 or the method of claim 2, characterized in that the light-absorbing material comprises a silica core and a gold shell.
[0013]
13. Use according to claim 1 or the method of claim 2, characterized in that the light-absorbing material has a diameter between about 0.01 microns and about 1.0 microns.
[0014]
14. Use according to claim 1 or the method of claim 2, characterized in that the light-absorbing material has a diameter between about 50 nm and about 250 nm.
[0015]
15. Use according to claim 1 or the method of claim 2, characterized in that the light-absorbing material is coated with PEG.
[0016]
16. Use according to claim 1 or the method of claim 2, characterized in that the light-absorbing material has an absorption peak of wavelength between 700 nm and 1100 nm.
[0017]
17. Use according to claim 1 or the method of claim 2, characterized in that the light-absorbing material has a ratio of shell diameter to core diameter between about 1.05 and about 2.0 .
[0018]
18. Use according to claim 1 or the method of claim 2, characterized in that the light-absorbing material is dispensed through one or more techniques selected from the group consisting of mechanical agitation, acoustic vibration, ultrasound, suction and alternating pressure and micro-jet generation.
[0019]
19. Use according to claim 1 or the method of claim 2, characterized in that the light-absorbing material is dispensed through ultrasound having a frequency between 20 kHz and 500 kHz.
[0020]
20. Use according to claim 1 or the method of claim 2, characterized in that the light-absorbing material is dispensed through ultrasound-induced bubbles the size of the hair follicle pores.
[0021]
21. Use according to claim 1 or the method of claim 2, characterized in that the light-absorbing material is dispensed with by applying a plurality of light pulses.

类似技术:

---

公开号 | 公开日 | 专利标题

---

BR112014026012B1|2021-04-20|use of a material that absorbs light, and method to improve the appearance of the skin or inhibit hair growth in an individual

---

JP2019123722A|2019-07-25|Compositions and methods for targeted thermomodulation

---

US20200338360A1|2020-10-29|Treatment intervals for use of compositions comprising energy absorbing materials for dermatological applications

---

US20180028659A1|2018-02-01|Compositions and methods comprising energy absorbing materials for follicular delivery

---

US20150190341A1|2015-07-09|Liquid Vehicle for Suspension of Undelivered Particles

---

JP2020058787A|2020-04-16|Liquid vehicle for suspension of undelivered particles

---

US20180325594A1|2018-11-15|Methods of treating skin conditions using plasmonic nanoparticles

同族专利:

---

公开号 | 公开日

---

US20200384017A1|2020-12-10|

---

CA2870474A1|2013-10-24|

---

JP2018193383A|2018-12-06|

---

AU2018200580A1|2018-02-15|

---

US20160310527A1|2016-10-27|

---

EP2838563B1|2020-03-11|

---

JP6974265B2|2021-12-01|

---

WO2013158278A1|2013-10-24|

---

EP2838563A4|2015-12-09|

---

KR20150008879A|2015-01-23|

---

AU2013249806A1|2014-10-23|

---

BR112014026012A2|2017-06-27|

---

IL235137D0|2014-12-31|

---

JP2015523960A|2015-08-20|

---

IL235137A|2020-06-30|

---

HK1207572A1|2016-02-05|

---

CA2870474C|2018-07-31|

---

CN104321080A|2015-01-28|

---

EP2838563A1|2015-02-25|

---

US20130315999A1|2013-11-28|

---

AU2020201649A1|2020-03-26|

---

AU2018200580B2|2019-12-05|

---

HK1206603A1|2016-01-15|

---

US20180353538A1|2018-12-13|

引用文献:

---

公开号 | 申请日 | 公开日 | 申请人 | 专利标题

---

---

US5817089A|1991-10-29|1998-10-06|Thermolase Corporation|Skin treatment process using laser|

---

US5423803A|1991-10-29|1995-06-13|Thermotrex Corporation|Skin surface peeling process using laser|

---

US5935596A|1997-03-20|1999-08-10|Chesebrough-Pond's Usa Co.|Delivery of skin benefit agents via adhesive strips|

---

US6283956B1|1998-11-30|2001-09-04|David H. McDaniels|Reduction, elimination, or stimulation of hair growth|

---

US6887260B1|1998-11-30|2005-05-03|Light Bioscience, Llc|Method and apparatus for acne treatment|

---

US6530944B2|2000-02-08|2003-03-11|Rice University|Optically-active nanoparticles for use in therapeutic and diagnostic methods|

---

IL159131D0|2001-06-01|2004-05-12|Lipo Chemicals Inc|Method of using optically-activated particles in cosmetic preparations|

---

WO2003026481A2|2001-09-26|2003-04-03|Rice University|Optically-absorbing nanoparticles for enhanced tissue repair|

---

US7226636B2|2003-07-31|2007-06-05|Los Alamos National Security, Llc|Gold-coated nanoparticles for use in biotechnology applications|

---

US20070078290A1|2005-09-30|2007-04-05|Esenaliev Rinat O|Ultrasound-based treatment methods for therapeutic treatment of skin and subcutaneous tissues|

---

EP2532320A3|2007-04-19|2013-04-03|Miramar Labs, Inc.|Apparatus for reducing sweat production|

---

US20090177122A1|2007-12-28|2009-07-09|Celleration, Inc.|Methods for treating inflammatory skin disorders|

---

US20100119610A1|2008-11-12|2010-05-13|Concurrent Analytical, Inc.|Packaged pegylated gold nanoparticles|

---

US8961450B2|2009-05-26|2015-02-24|The General Hospital Corporation|Method and apparatus for dermal delivery of a substance|

---

WO2011095970A1|2010-02-07|2011-08-11|J.P.M.E.D. Ltd.|Hair follicle targeting compositions|

---

ES2637373T3|2010-08-27|2017-10-13|Sienna Biopharmaceuticals, Inc.|Compositions and methods for directed thermomodulation|

---

US20130315999A1|2012-04-20|2013-11-28|The General Hospital Corporation|Compositions and methods comprising energy absorbing compoundfs for follicular delivery|US9572880B2|2010-08-27|2017-02-21|Sienna Biopharmaceuticals, Inc.|Ultrasound delivery of nanoparticles|

---

ES2637373T3|2010-08-27|2017-10-13|Sienna Biopharmaceuticals, Inc.|Compositions and methods for directed thermomodulation|

---

US20130315999A1|2012-04-20|2013-11-28|The General Hospital Corporation|Compositions and methods comprising energy absorbing compoundfs for follicular delivery|

---

ES2629903T3|2012-10-11|2017-08-16|Nanocomposix, Inc.|Compositions and method of silver nanoplates|

---

CA2906887A1|2013-03-15|2014-09-18|The Regents Of The University Of California|Methods of delivering nanoshells into sebaceous glands|

---

WO2015106151A1|2014-01-10|2015-07-16|Sebacia, Inc.|Liquid vehicle for suspension of undelivered particles|

---

MX2016009051A|2014-01-10|2017-02-06|Sebacia Inc|Sub-surface array of absorber materials, and light irradiation therapy.|

---

JP2017502090A|2014-01-10|2017-01-19|セバシア，インコーポレイテッド|Treatment interval for the use of compositions containing energy absorbing substances for dermatological applications|

---

US20150196452A1|2014-01-10|2015-07-16|Sebacia, Inc.|Particle containers and delivery applicators|

---

EP3362145B1|2015-10-15|2021-01-06|DUSA Pharmaceuticals, Inc.|Adjustable illuminator for photodynamic therapy and diagnosis|

---

JP2018533613A|2015-11-13|2018-11-15|セバシア，インコーポレイテッド|Method of treating skin condition using plasmonic nanoparticles|

---

US10376985B2|2015-12-18|2019-08-13|General Electric Company|System and method for shaping a ceramic matrix compositesheet|

---

US10357567B1|2018-01-12|2019-07-23|Dusa Pharmaceuticals, Inc.|Methods for photodynamic therapy|

---

CN109458742B|2018-09-21|2020-02-18|福建师范大学|Photo-thermal conversion structure, preparation method thereof and solar distillation device|

---

CN111500265A|2020-02-21|2020-08-07|南京理工大学|Double-layer core-shell structure nanoparticle with adjustable surface temperature|

法律状态:
2018-01-23| B07D| Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]|

---

2018-03-27| B06F| Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]|

---

2019-01-29| B07E| Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]|Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI |

---

2019-08-20| B06U| Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]|

---

2019-09-03| B06I| Publication of requirement cancelled [chapter 6.9 patent gazette]|Free format text: ANULADA A PUBLICACAO CODIGO 6.21 NA RPI NO 2537 DE 20/08/2019 POR TER SIDO INDEVIDA. |

---

2020-09-24| B07A| Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]|

---

2021-01-26| B09A| Decision: intention to grant [chapter 9.1 patent gazette]|

---

2021-04-20| B16A| Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]|Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 14/03/2013, OBSERVADAS AS CONDICOES LEGAIS. |

优先权:

---

申请号 | 申请日 | 专利标题

---

US201261636381P| true| 2012-04-20|2012-04-20|

---

US61/636,381|2012-04-20|

---

US13/789,575|US20130315999A1|2012-04-20|2013-03-07|Compositions and methods comprising energy absorbing compoundfs for follicular delivery|

---

US13/789,575|2013-03-07|

---

PCT/US2013/031658|WO2013158278A1|2012-04-20|2013-03-14|Compositions and methods comprising energy absorbing materials for follicular delivery|

---